{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:34:59Z","timestamp":1782995699459,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijid.2026.108742","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:46:03Z","timestamp":1777308363000},"page":"108742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clindamycin demonstrates clinical effectiveness for bacteremic M1UK Streptococcus pyogenes pneumonia: A case report and in vitro evidence of notable antitoxin effects on M1UK"],"prefix":"10.1016","volume":"168","author":[{"given":"Masayoshi","family":"Ezaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Manh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-101X","authenticated-orcid":false,"given":"Hitoshi","family":"Kawasuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Takegoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijid.2026.108742_bib0001","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: united States, 2000-2004","volume":"45","author":"O\u2019Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108742_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the Diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108742_bib0003","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-024-47929-7","article-title":"Rapid expansion and international spread of M1(UK) in the post-pandemic UK upsurge of Streptococcus pyogenes","volume":"15","author":"Vieira","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ijid.2026.108742_bib0004","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1473-3099(19)30446-3","article-title":"Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study","volume":"19","author":"Lynskey","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.108742_bib0005","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/eid2908.230569","article-title":"Increase of severe pulmonary infections in adults caused by M1(UK) Streptococcus pyogenes, Central Scotland, UK","volume":"29","author":"Davies","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108742_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13613-024-01249-7","article-title":"Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series","volume":"14","author":"Peetermans","year":"2024","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijid.2026.108742_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107246","article-title":"COVID-19 complicated with severe M1(UK)-lineage Streptococcus pyogenes infection in elderly patients: a report of two cases","volume":"148","author":"Kawaguchi","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2026.108742_bib0008","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1086\/375348","article-title":"Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci","volume":"187","author":"Miyoshi-Akiyama","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108742_bib0009","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-023-36717-4","article-title":"Detection of Streptococcus pyogenes M1(UK) in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA","volume":"14","author":"Davies","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ijid.2026.108742_bib0010","first-page":"269","article-title":"Clindamycin affects group A Streptococcus virulence factors and improves clinical outcome","volume":"215","author":"Andreoni","year":"2016","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2026.108742_bib0011","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3201\/eid3104.241076","article-title":"Emerging trends in streptococcal toxic Shock syndrome, Japan","volume":"31","author":"Ujiie","year":"2025","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2026.108742_bib0012","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/ofid\/ofz360.545","article-title":"472. Rethinking the role of clindamycin for toxin-mediated illnesses","volume":"6","author":"Saldarriaga Perez","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2026.108742_bib0013","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/ofid\/ofz360.546","article-title":"473. Impact of adjunctive clindamycin in invasive \u03b2-hemolytic streptococcal infections: a propensity score-matched analysis of 1956 \u03b2-lactam treated patients from 118 US hospitals","volume":"6","author":"Babiker","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2026.108742_bib0014","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1473-3099(24)00507-3","article-title":"Adjunctive linezolid versus clindamycin for toxin inhibition in \u03b2-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation","volume":"25","author":"Babiker","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"Supplement_2","key":"10.1016\/j.ijid.2026.108742_bib0015","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/20.Supplement_2.S154","article-title":"Antibiotic effects on bacterial viability, toxin production, and host response","volume":"20","author":"Stevens","year":"1995","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:15:48Z","timestamp":1781460948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226003772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"alternative-id":["S1201971226003772"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108742","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clindamycin demonstrates clinical effectiveness for bacteremic M1UK Streptococcus pyogenes pneumonia: A case report and in vitro evidence of notable antitoxin effects on M1UK","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108742"}}